Selbyville, Delaware, Sept. 25, 2024 (GLOBE NEWSWIRE) --
Microcarriers Market size is estimated to reach USD 4 billion by the end of 2032 driven by the rising demand for cell-based therapies and regenerative medicine.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/8058
As biopharmaceutical companies focus on developing innovative treatments for chronic diseases, including cancer and autoimmune disorders, microcarriers help in scaling up the production of adherent cells in bioreactors. This ability to support the growth of large cell quantities in small volumes makes them essential for efficient manufacturing processes in cell culture.
With the growing prevalence of infectious diseases and the demand for effective vaccines, pharmaceutical companies are seeking scalable and cost-effective solutions for mass production. As per reports, in 2021, over 362,600 hospitalizations occurred due to infectious diseases. Microcarriers enable high-yield production of viral vectors and vaccines, particularly in the development of viral-based therapies. The expansion of biopharmaceutical research and the rising focus on personalized medicine have further created significant opportunities for the industry progression.
Rising demand for microcarrier equipment
In terms of product, the microcarriers market size from the equipment segment is likely to accelerate at a robust pace between 2024 and 2032 as advanced bioreactor systems and cell culture equipment are crucial for optimizing microcarrier-based cell production. These technologies provide precise environmental control and scalability needed to support large-scale adherent cell cultures in pharmaceutical and biotechnological applications. Innovations in automated systems and specialized bioreactors designed for microcarrier use have also improved production efficiency whilst reducing labor costs and enhancing cell yield.
Regenerative medicine to gain traction
In terms of application, the microcarriers market from the regenerative medicine segment is anticipated to witness substantial expansion from 2024 to 2032 due to the increasing need for scalable and efficient cell expansion techniques. Regenerative therapies support high-density cell cultures in bioreactors. Microcarriers enhance the development of these cells in three-dimensional environments, making them ideal for developing tissue engineering, gene therapy, and stem cell-based treatments. As regenerative medicine advances, the demand for microcarriers grows, facilitating the production of cells needed for these cutting-edge therapies.
Asia Pacific to emerge as a lucrative market
Asia Pacific microcarriers market is estimated to attain substantial valuation by 2032 driven by the expanding biopharmaceutical sector and increasing investments in cell-based therapies and vaccine production across the region. Countries like China, India, and South Korea are witnessing significant advancements in biotechnology research, fueling the demand for efficient cell culture technologies like microcarriers. The rise in government initiatives is also supporting regenerative medicine and biologics manufacturing, along with the growing healthcare infrastructure.
Request for Report Customization @ https://www.gminsights.com/roc/8058
Microcarriers Market Participants
Some of the prominent microcarriers industry players include Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Sartorious AG, Corning Incorporated, Merck KGaA, Cytiva, Lonza Group Ltd., denovoMATRIX GmbH, Fujiform Holdings Corporation, and Eppendorf AG. These firms are working on collaborations, acquisitions, and mergers to widen their product portfolio. For instance, in April 2024, Kuraray Co., Ltd. created Polyvinyl Alcohol hydrogel microcarriers designed for cell cultures in regenerative medicine.
Partial Table of Contents (ToC) of the report:
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast calculation
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing cases of cancer and chronic diseases
3.2.1.2 Advancements in cell culture technologies
3.2.1.3 Rising investments in biotechnology and life sciences
3.2.2 Industry pitfalls & challenges
3.2.2.1 Biocompatibility and immunogenicity concerns
3.2.2.2 High cost associated with serum-free media
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter’s analysis
3.5.1 Supplier power
3.5.2 Buyer power
3.5.3 Threat of new entrants
3.5.4 Threat of substitutes
3.5.5 Industry rivalry
3.6 PESTEL analysis
Browse more biotechnology R&D industry reports @ https://www.gminsights.com/industry-reports/biotechnology-randd/82
About Global Market Insights
Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.
